The Biden administration has faced pressure to help other countries with their vaccination efforts.
Some Canadians are heading to the United States. to get a COVID-19 shot as Canada struggles to keep up with vaccine demand amid a third COVID-19 wave.
It’s pursuing options to generate oxygen on an ‘urgent basis’.
As we rapidly approach the point where the Covid-19 vaccine is available to all those who want it, the key constraint on reaching a sufficiently high level of vaccinations to achieve herd immunity is the hesitancy of certain groups to get vaccinated. The latest survey data from the Kaiser Family Foundation breaks them down. As one can see in the first chart, 10 percent of Black adults refuse to get vaccinated—which, fortunately, is down from 27 percent in October 2020—with 7 percent saying they...
The drugmakers may skip asking the U.S. FDA for emergency-use authorization for its COVID-19 shot and instead pursue the more time-intensive application for a full-fledged license.
White House Covid adviser Andy Slavitt said in a tweet Monday that doses would be sent to other countries “as soon as they become available.”
The Biden administration announced Sunday that it will send assistance to India, a country whose COVID-19 daily case rate has exceeded a record-setting 350,000 cases. Reports from the country are horrifying: Many hospitals' oxygen supply has all but run out, and they are being forced to turn away dying patients.
The move greatly expands on the Biden administration's action last month to share about 4 million doses of the vaccine with Mexico and Canada.
The U.S. will share 60 million doses of AstraZeneca's Covid-19 vaccine with other countries as cases continue to spike worldwide, a U.S. official said Monday.
The administration has faced growing calls to send its stockpile of the AstraZeneca vaccine, which is not yet cleared for use in the U.S., to help countries hit hard by the virus.
More than 120 retired generals and admirals have published an open letter questioning the legitimacy of the 2020 presidential election as well as President Biden's fitness to be commander-in-chief.
Federal officials have cleared the Johnson & Johnson covid-19 vaccine for use in the United States once again, albeit with an updated label to warn of blood clot risks. The Food and Drug Administration and the Centres for Disease Control and Prevention called for a pause on the vaccine’s use